☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Orphan Drug Designation
New Drug Designations - August 2023
September 18, 2023
Coherus and Junshi's Toripalimab Receive the US FDA's Orphan Drug Designation for the Treatment of Esophageal Cancer
November 16, 2021
PharmaTher's Ketamine Receives the US FDA's Orphan Drug Designation for Complex Regional Pain Syndrome
October 14, 2021
C4T's CFT7455 Receives the US FDA's Orphan Drug designation for the Treatment of Multiple Myeloma
August 12, 2021
LEXEO Therapeutics' LX2006 Receives the US FDA's Rare Pediatric Disease Designation and Orphan Drug Designation to Treat Friedreic...
July 1, 2021
Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis
May 28, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.